Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lilly(Eli) & Co shares valued at $716,410 were sold by Zakrowski Donald A on May 27 ’25. At $716.41 per share, Zakrowski Donald A sold 1,000 shares. The insider’s holdings dropped to 4,840 shares worth approximately $3.69 million following the completion of this transaction.
Also, Yuffa Ilya sold 1,250 shares, netting a total of over 936,550 in proceeds. Following the sale of shares at $749.24 each, the insider now holds 27,510 shares.
Before that, Yuffa Ilya had added 2,500 shares to its account. In a trade valued at $1,873,100, the Officer bought Lilly(Eli) & Co shares for $749.24 each.
As published in a research note from Erste Group on June 05, 2025, Lilly(Eli) & Co [LLY] has been rated down from a Buy to a Hold. Analysts at HSBC Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Reduce”‘ outlook in a report released in late April. As of April 22, 2025, Cantor Fitzgerald has initiated its “an Overweight” rating for LLY.
Analyzing LLY Stock Performance
On last trading session,, Lilly(Eli) & Co [NYSE: LLY] plunged -3.58% to $761.5. The stock’s lowest price that day was $760.0201, but it reached a high of $789.9155 in the same session. During the last five days, there has been a drop of approximately -3.69%. Over the course of the year, Lilly(Eli) & Co shares have dropped approximately -19.88%.
Support And Resistance Levels for Lilly(Eli) & Co (LLY)
RSI (Relative Strength Index) is 43.71 on the 14-day chart, showing neutral technical sentiment.
Is Lilly(Eli) & Co subject to short interest?
Stocks of Lilly(Eli) & Co saw a sharp rise in short interest on 2025-06-13 jumping by 0.67 million shares to 8.02 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 7.35 million shares. A jump of 8.33% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.13 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.13.
Which companies own the most shares of Lilly(Eli) & Co (LLY)?
In terms of Lilly(Eli) & Co share price expectations, FactSet research, analysts set an average price target of 1050 in the next 12 months, up nearly 32.95% from the previous closing price of $789.8. Analysts anticipate Lilly(Eli) & Co stock to reach 1146 by 2025, with the lowest price target being 700. In spite of this, 19 analysts ranked Lilly(Eli) & Co stock as Buy at the end of 2025. On November 15, 2024, Wolfe Research assigned a price target of “an Outperform” to the stock and initiated coverage with a $1000.
